Audit Trail · Article #2390504

Clinical trials to begin in Vancouver after study finds lactation drug could reduce breast cancer risk

Source article ↗ · Vancouver Sun · outlet lean: center-right · owner: Postmedia (corporate)

published 2026-10-22T13:00:54 · ingested 2026-10-22T09:25:36.604462

Bias Analysis · B.I.A.S.

CENTER score: 0.10 vv3

The article does not present a biased view but leans slightly towards the positive impact of scientific research on public health.

Trigger phrases: could reduce breast cancer riskunexpected discovery

      computed at 2026-10-22T09:43:00.428188
    

ML Bias Signal · DistilBERT Zero-Shot (v2)

CENTER score: 0.000 confidence: 37% valhalla/distilbart-mnli-12-3

      computed at 2026-10-22T09:38:54.335571-04:00
    

Ensemble (heuristic + ML v2)

CENTER score: 0.000

Analysis Tier

Tier: quick_v1+full

Tier-1 at: 2026-10-22T09:43:00.428188

Tier-2 at: 2026-10-22T09:43:00.428188

AI analyzed: ✓ at 2026-10-22T09:43:00.428188

Geographic Extraction · L.O.C.A.L.

Country: CA

Province: BC

Scope: provincial

Fact-Check Claims · V.E.R.I.F.Y. (2)

unverified Clinical trials will begin in Vancouver after a study found that women who took cabergoline were much less likely to develop breast cancer than those who didn't take the drug.

        fact_v1 · 2026-10-22T09:43:04.227265
      

unverified Scientists have discovered that the lactation drug cabergoline could reduce the risk of breast cancer in mothers.

        fact_v1 · 2026-10-22T09:43:04.227265
      

Cross-Outlet Cluster · I.N.K.

Clinical trials to begin in Vancouver after study finds lactation drug could reduce breast cancer risk 1 article across outlets

      clustered at 2026-10-22T09:25:36.610085
    

Governance — C.R.E.E.D.

A+

overall grade

100.0

By Category

Accountability {'events': 0, 'grade': 'A+', 'note': 'no events recorded', 'provisional': True, 'score': 100.0}

Environmental {'events': 0, 'grade': 'A+', 'note': 'no events recorded', 'provisional': True, 'score': 100.0}

Fairness {'events': 3, 'grade': 'A+', 'note': 'below minimum volume (3 events; minimum 100 for a non-provisional score)', 'provisional': True, 'score': 100.0}

Privacy {'events': 0, 'grade': 'A+', 'note': 'no events recorded', 'provisional': True, 'score': 100.0}

Safety {'events': 0, 'grade': 'A+', 'note': 'no events recorded', 'provisional': True, 'score': 100.0}

Transparency {'events': 0, 'grade': 'A+', 'note': 'no events recorded', 'provisional': True, 'score': 100.0}

Ethics audit by C.R.E.E.D. Institute · 3 events tracked

Raw Audit Trail (2 events)

2026-10-22T09:25:36.604462 ingested

payload

{
  "bias": {
    "band": "center",
    "heuristic_version": "v3",
    "rationale": "triggers: scientists(+0.00\u00d71)",
    "score": 0.0,
    "signal_detected": false
  },
  "source_id": 593
}

2026-10-22T09:38:54.335571 bias_v2_scored

payload

{
  "confidence": 0.372,
  "ensemble_band": "center",
  "ensemble_score": 0.0,
  "label": "center",
  "model": "valhalla/distilbart-mnli-12-3",
  "score": 0.0
}

Every signal computed about this article, with timestamps. Source for the transparency promise behind our methodology.